What Happened?
Toronto, ON-based ChroMedX Appointed Igal Roytblat as Chief Technology Officer
About the Company
ChroMedX Corp. is a medical technology company focused on the development of novel, handheld medical devices for diagnostic testing at the patient`s bedside. HemoPalm, the Company`s lead product is the only handheld blood analysis system which combines Blood Gases & Electrolytes with full CO-oximetry. It has a single-use cartridge/handheld reader format, providing the simplest, most rapid and accurate testing process for use in management of critical care patients. Current blood gas systems require purchase of a second device to carry out CO-oximetry measurements. In addition, HemoPalm has the ability to draw capillary blood directly from pin-prick sites into the cartridge, as an alternative to the commonly required, risk-associated arterial blood draws. ChroMedX Corp. technologies are protected by the Company`s issued and pending patents, covering blood/plasma/serum collection, and processing and analysis.
About the Person
Igal Roytblat is Chief Technology Officer at ChroMedX. Previously, Igal held various senior IT leadership roles in the industry.
Info Source
Press Release
Short Profile